-
1
Supplementary Figure 5: Pathway analysis after treatment with KC and KCM serum in precursor cells
Wydane 2025Hasła przedmiotowe: -
2
-
3
Supplementary Figure 4: RNA-sequencing in the primary AD-MSCs, BM-MSCs, and PSCs after treatment with KC and KCM serum
Wydane 2025Hasła przedmiotowe: -
4
-
5
Supplementary Figure 2: Pathway analysis in AD-MSCs and PSCs activated by Muc5ac
Wydane 2025Hasła przedmiotowe: -
6
-
7
-
8
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
9
Supplementary Table S1 from G-Quadruplex Structures Are Key Modulators of Somatic Structural Variants in Cancers
Wydane 2025Hasła przedmiotowe: -
10
-
11
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
12
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
13
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
14
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
15
-
16
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
17
-
18
-
19
Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
Wydane 2025Hasła przedmiotowe: -
20